Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Covington Represents India-Based Healthcare Company In Drug Portfolio Acquisition

Press Release January 30, 2017

  • News and Insights
  • Covington Represents India-Based Healthcare Company In Drug Portfolio Acquisition

Covington Represents India-Based Healthcare Company In Drug Portfolio Acquisition

January 30, 2017

WASHINGTON—Covington represented India-based Piramal Enterprises and its wholly owned Critical Care subsidiary in the UK in its agreement to acquire a portfolio of intrathecal spasticity and pain management drugs from Mallinckrodt LLC. 

The purchase price was $171 million, plus an earn-out of up to an additional $32 million. This is the third acquisition that Covington has led for Piramal over the past six months.

The Covington team included Ralph Voltmer and Brian Yang (corporate); Jim O’Connell, Megan Gerking and Habin Chung (antitrust); Michael Francese and Victoria Ha (employee benefits);  Peter Safir and Christina Kuhn (food & drug regulatory); Stefanie Doebler (health care compliance); Adrian Perry and David Wildman (intellectual property); Sara Needles (life sciences); and Rob Heller and John Oldak (tax).

Related Professionals

Share links:

Share links:

Related Practices

Related Industries

Related Offices

Related Regions

Related News & Insights